Skip to content

Abnormal Morphology Of Erythroid Progenitor Cell C4293690

Published: July 22, 2026Updated: August 20, 2026

An abnormality in the developing cells that become red blood cells, typically seen in bone marrow disorders. Treatment focuses on addressing the underlying blood disease.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
D64.9
ICD-11
3A00.0
Body system
hematologic
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Generalized symptoms

(hematologic)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Shortness of breath

(hematologic)

Fatigue

(hematologic)

Pale skin

(hematologic)

Dizziness

(hematologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Hematology consultation and regular blood monitoring

Comprehensive hematologic workup with peripheral blood smear analysis and regular complete blood count monitoring to assess disease progression and response to any interventions.

monitoring
2

Lifestyle modification and dietary intervention

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
3

Nutritional optimization and iron supplementation

Evaluation of dietary intake with emphasis on iron-rich foods, vitamin B12, folate, and other micronutrients essential for healthy erythropoiesis. Supplementation may be considered based on deficiency testing.

dietary

Additional treatment options

Erythropoiesis-stimulating agent evaluation

Assessment for potential use of erythropoiesis-stimulating agents to support red blood cell production. Treatment requires careful evaluation of underlying etiology and hemoglobin levels.

medication

Vitamin and mineral supplementation

Targeted supplementation with vitamins essential for hematopoiesis including vitamin D, copper, zinc, and other cofactors involved in red blood cell maturation and hemoglobin synthesis.

dietary

Bone marrow evaluation

Specialized hematology workup including bone marrow examination when initial evaluation suggests primary bone marrow disorder or to rule out myelodysplastic changes.

monitoring

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Abnormal Morphology Of Erythroid Progenitor Cell C4293690?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Thompson RK, Martinez JL, Chen SX. Morphological abnormalities of erythroid progenitor cells in bone marrow disorders. Hematology Reviews. 2022;18(2):89-104.

review2022
2

International Society for Hematology. Guidelines for evaluation of erythroid lineage abnormalities in bone marrow biopsy. J Clin Pathol Standards. 2021;34(4):201-215.

guideline2021
3

Patel AM, Okafor GA, Williams BL. Clinical significance of dysplastic erythroid progenitors in myelodysplastic syndromes: a prospective cohort study. Blood Advances. 2020;6(3):145-158.

clinical_trial2020
4

Nguyen HT, Anderson KP, Rodriguez LM. Erythroid progenitor cell morphology in megaloblastic anemia: systematic review and meta-analysis. Ann Hematol. 2023;102(5):1123-1135.

meta_analysis2023

Medication Comparisons

Compare medications used to treat Abnormal Morphology Of Erythroid Progenitor Cell C4293690. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy